Dr. Agarwal's Health Care Limited (BOM:544350)

Market Cap	144.16B
Revenue (ttm)	19.76B +23.5%
Net Income	1.26B +40.6%
EPS	3.96 +28.5%
Shares Out	n/a
PE Ratio	114.37
Forward PE	86.29
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,712
Average Volume	38,658
Open	454.85
Previous Close	458.50
Day's Range	448.00 - 456.35
52-Week Range	327.40 - 567.80
Beta	n/a
RSI	43.60
Earnings Date	Feb 3, 2026

About Dr. Agarwal's Health Care

Dr. Agarwal's Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens. The company also provides surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty, and surgeries for the tr...

• Industry: Health Services
• Founded: 2010
• Country: India
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544350

Financial Performance

In fiscal year 2025, Dr. Agarwal's Health Care's revenue was 17.11 billion, an increase of 28.44% compared to the previous year's 13.32 billion. Earnings were 834.60 million, an increase of 0.48%.